MIST
NASDAQ · Pharmaceuticals
Milestone Pharmaceuticals In
$1.22
+0.06 (+5.17%)
Open$1.18
Previous Close$1.16
Day High$1.25
Day Low$1.17
52W High$3.06
52W Low$0.63
Volume—
Avg Volume1.38M
Market Cap144.79M
P/E Ratio—
EPS$-0.89
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+3,623.8% upside
Current
$1.22
$1.22
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.43M | 19.07M | 23.97M |
| Net Income | 7.18M | 5.86M | 8.22M |
| Profit Margin | 33.5% | 30.7% | 34.3% |
| EBITDA | 12.24M | 12.52M | 14.11M |
| Free Cash Flow | 4.04M | 4.46M | 4.28M |
| Rev Growth | +15.6% | +19.4% | -5.5% |
| Debt/Equity | 0.51 | 0.56 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |